The platelet-specific alloantigen, Sib', located within the a-subunit of the glycoprotein (GP) Ib-IX membrane receptor, has been found to be involved in the pathogenesis of platelet transfusion refractoriness. We have identified the existence of a naturally occurring threonine/ methionine dimorphism at position 145 of the GPlba sequence, and determined that the Siba antigen corresponds to the molecule containing methionine'&. The diallelic codons can be detected by restriction enzyme analysis of amplified genomic DNA fragments from the GPlba gene. Evaluation of 61 healthy blood donors showed that the allele frequencies are 89% and 11% for the threonine'" and methionine'* codons, respectively. A posi-LATELET ALLOANTIGEN systems are responsible P for the pathogenesis of various clinical disorders, including neonatal alloimmune thrombocytopenic purpura, posttransfusion purpura, and platelet transfusion refractoriness.' The alloantigens PIA1 and PIAz are frequently responsible for the development of neonatal alloimmune thrombocytopenic purpura and posttransfusion purpura, and are defined by an amino acid polymorphism within the platelet membrane glycoprotein (GP) IIIa molecule.2 Platelet transfusion refractoriness is most frequently caused by anti-HLA alloantibodies, although a significant number of patients remain in a refractory state even after transfusion with HLA-matched platelets. The development of platelet transfusion refractoriness with HLA-matched platelets can be related to the platelet-specific antigen, originally identified by the characterization of an IgG antibody, anti-Siba, present in the serum of a patient who became refractory to platelet transfusion! Recent studies have demonstrated that the Siba antigen is associated with the a-chain of the platelet membrane GPIb-IX c o m p l e~.~ Platelet GPIb-IX is a receptor for the adhesive glycoprotein von Willebrand factor and is a binding site for
thrombin6; it is composed of three distinct gene products, the covalently linked a-and @-chains of GPIb and the noncovalently associated subunit, GPIX.6 Presumably, GPIba contains naturally occurring structural differences which, during platelet transfusion, result in nonmatched platelet phenotypes between the donor and recipient. In this report we describe an amino acid dimorphism at position 145 of the a-subunit of GPIb and establish that the dimorphism is responsible for the Siba alloantigen system. These results provide a structural explanation for the generation of the anti-Siba antibody and indicate one additional possibility to match platelets for the prevention of platelet transfusion refractoriness.
MATERIALS AND METHODS
Polymerase chain reaction, DNA sequence, and restriction enzyme analysis. Genomic DNA was isolated after informed consent from the peripheral blood lymphocytes of healthy blood donors recruited at the General Clinic Research Center facility of the Scripps Clinic? Two oligonucleotide primers, Iba-3 (S'GGACGTC-TCCTTCAACCGGC3') and Iba-4 (5'GCTTTGGTGGGGAACT-TGAC3') were used in a polymerase chain reaction (PCR) to generate a 591-base pair (bp) fragment that corresponds to the GPIba coding sequence for residues 106 to 302. The fragment was amplified using a DNA thermal cycler (Perkin Elmer-Cetus, Norwalk, CT) in a final volume of 100 ILL containing 10 mmol/L Tris (pH 8.3), 50 mmol/L KCl, 1.3 mmol1L MgC12, 0.01% gelatin, 0.2 mmol1L of each deoxynucleotide triphosphate, 0.5 kg of genomic DNA, and 2.5 U Taq polymerase. The fragment was generated from a 30-cycle PCR consisting of 94°C for 30 seconds, 52°C for 30 seconds, and 72°C for 60 seconds. Cloning of the amplified fragments into M13mp18 and subsequent DNA sequence analysis was performed using standard technique^.^*^ The restriction enzyme Aha11 was purchased from New England BioLabs (Beverly, MA) and DNA digestion with this enzyme was allowed to proceed for 3 hours at 37°C. The resulting products were separated and visualized in a 2% agarose gel.
Anti-Sib" antibody and the detection of S i p antigen on platelets. Serum containing the anti-Siba antibody used in this study was from the original propositus reported by Saji et al ! Platelet reactivity with the anti-Siba antibody was evaluated using a previously described modified antigen capture enzyme-linked immunoadsorbent assay (ELISA)? One hundred microliters of washed platelets (1 x 109/mL) were mixed with 5 to 20 WL of the anti-Siba serum for 1 hour at 22 to 25"C, and the platelets were lysed with phosphatebuffered saline (PBS) containing 10 mmol/L EDTA and 1% Triton X-100. The lysate was centrifuged (11,750 x g ) to remove the GP Iba DIMORPHISM AND PLATELET TRANSFUSION 3087 insoluble debris and the supernatant was incubated (60 minutes) in a microtiter plate coated with the anti-GPIb-IX monoclonal antibody SZ1 (Immunotech, Marseille, France). The antibody, SZ1, is directed against an epitope in the human GPIb-IX complex and was coated in microtiter plate wells by an overnight incubation (3 kg/mL) at 4°C followed by washing with PBS containing 0.05% Tween 20. The amount of anti-Siba antigen immune complex bound to SZ1 was determined using a biotinylated goat anti-human IgG (Tago, Burlingame, CA) and subsequent incubation with alkaline phosphatase-streptavidin (Zymed, San Francisco, CA). Color development was monitored after the addition of substrate by determining the OD405 in a microplate reader (Bio-Rad, Richmond, CA). Results were expressed as an OD ratio defined as:
(sample OD -mean OD of negative controls)/mean OD of negative controls?
Construction of expression plasmids and generation of recombinant antigens. The construction and characterization of the expression plasmid, pMW2, has been described in detail elsewhere.1° Briefly, pMW2 directs the secretion from heterologous cells of a soluble fragment of GPIba, composed of residues H i~~-A l a~~* .
The secreted GPIba fragment and the GPIb-IX complex on platelets bind von Willebrand factor with an almost identical affinity in the presence of the appropriate modulators.1° For the purpose of clarity, in this report, pMW2 is designated ~M W 2 / T h r l~~ to indicate a threonine codon at position 145. ~M W 2 / M e t l~~ was constructed via site-directed mutagenesis substituting the threonine codon with the methionine codon. The mutagenesis strategy was identical to that previously described,I0 and the resultant expression constructs, ~M W 2 / T h r l~~ and pMW2/Met1", are identical with the exception of the codons at position 145.
~M W 2 / T h r l~~ and ~M W 2 / M e t l~~ were transfected into CHO-K1 cells using a calcium-phosphate-mediated transfection procedure. Stable cell lines resistant to Geneticin (Sigma, St Louis, MO) were screened for the production of GPIba antigen using two murine monoclonal antibodies, LT-Ibal and LJ-P3, which have been previously described and recognize distinct epitopes located within the amino-terminal 45-Kd tryptic fragment, residues 1 to 293, of Immunoreactivity of the anti-Sib" antibody with recombinant GPIba fragments. Culture medium from cells transfected with either ~M W 2 / T h r l~~ or ~M W 2 / M e t l~~ was assayed for the content of GPIba antigen by a dot blot technique using a commercial apparatus (Pierce Chemical, Rockford, IL). The methodology involved has been described in detail previously,1° and is based on binding circular disks of a nitrocellulose membrane with defined quantities of the test sample containing the antigen. GPIba antigen was measured by determining its reactivity with a specific rabbit antiserum obtained by immunization with a synthetic peptide corresponding to GPIba residues Gly271-G1~28S. The antigencoated membrane was incubated for 2 hours at 22 to 25°C with the anti-GPIb~t"'-~~ serum diluted 1:200 in Blotto (a solution composed of 50 mg/mL fat-free milk, 0.25 mmol/L phenylmethylsulfonyl fluoride, 0.15 mol/L NaCl, in PBS). At the end of the incubation, the membrane was washed three times in Blotto, incubated for 1 hour with 1251-labeled goat anti-rabbit IgG, and washed again three times in Blotto. Disks of the nitrocellulose membrane corresponding to the position of each application well were cut out and the amount of bound radioactivity was determined with a y-scintillation spectrometer. The amount of radioactivity bound to each application well was proportional to the amount of GPIba antigen bound to the nitrocellulose membrane. Based on the results of this assay, culture media were diluted to obtain identical amounts of GPIba antigen.
After normalization of recombinant antigen levels, culture media were tested for their reactivity with the anti-Siba antibody GP Iba."J2 using the same dot blot technique. Culture media were vacuumdrawn through a nitrocellulose membrane, blocked with Blotto for 2 hours at 22 to 25"C, and then incubated for 2 hours with serum containing the anti-Siba antibody or normal serum (1:20 dilutions). After three cycles of washing in Tris-buffered saline (10 mmol/L Tris, pH 7.5; 140 mmol/L NaCI) containing 5% fat-free milk, the membrane was transferred into a solution of horseradish peroxidaseconjugated goat anti-human IgG (1:500, Zymed) for 2 hours. The membrane was finally washed three times with Tris-buffered saline and incubated in a solution containing 0-phenylendiamine (Zymed) and hydrogen peroxide to develop color.
RESULTS AND DISCUSSION
Identification of a dimorphic codon within the a-subunit gene of GPIb. The nucleotide sequence of the GPIba gene has been independently reported by two different laboratories from cDNA13 and genomic DNA clones,14 and both reports are in complete agreement for the GPIba coding sequence. However, the generation and characterization of the anti-Sib" antibody suggests that genetic polymorphisms must exist in the GPIba coding sequence. We exploited the lack of introns within the coding sequence for GPIba to amplify genomic DNA fragments of the GPIba gene in an attempt to identify the genetic bases of the Siba antigen. Figure 1 schematically illustrates the PCR strategy used to generate a 591-bp fragment of the GPIba gene that codes for amino acid residues 106 to 302. PCRs were performed on genomic DNA isolated from several healthy individuals whose platelets reacted with the anti-Siba antibody. The amplified DNA fragments were cloned into M13mp18 for DNA sequence analysis. As compared with the published GPIba nucleotide sequence, the sequence analysis showed a cytosine to thymine transition at position 1018 (numbers according to Wenger et all4) in several of the cloned fragments from these individuals. The obsemed nucleotide transition demonstrated that the threonine145 ACG codon, matching the reported GPIba sequences, may be substituted in some individuals by a methionine145 ATG codon. The nucleotide transition abrogates an Aha11 restriction site within the amplified 591-bp fragment (Fig l) , thus providing a characterization of this polymorphism by simple analysis of the pattern generated by digestion of amplified fragments withAhaI1.
To determine the frequency of Thr/Met145-encoding alleles in the normal population, genomic DNA from 61 healthy blood donors was subjected to PCR analysis and digestion with AhaII. A representative agarose gel analysis is shown to illustrate the observed genotypes (Fig 1) . Within the sampling of a normal population, the expected three genotypes related to codon 145 were observed; some individuals contained two alleles coding for Met145, some contained two alleles coding for Thr145, and some were heterozygous, containing one allele coding for Met145 and one allele coding for Thr145. The cumulative results are displayed in Table 1 and show allele frequencies of 89% and 11% for the Thr145 and Met145 codons, respectively. The allele frequencies within a population of restricted ethnic origin may differ from those reported in Table 1 ; however, our findings suggest that in a random population of diverse ethnic groups, a Thr145 codon is the more prevalent form. Correlation between the Si@ antigen and the dimorphism of residue I45 in GPIba. To determine if the Thr/Met145 dimorphism could be associated with the Siba antigen system, we analyzed platelets from nine normal individuals for their reactivity with the anti-Siba antibody (Table 2) . After establishing platelet reactivity with the anti-Siba (9) 2(2) 13(11) antibody, we determined the genotype of each individual as described above. The results demonstrated a positive correlation between platelet reactivity with the anti-Siba antibody and the presence of at least one Met145-encoding allele (Table 2) . Indeed, the results demonstrated that the individual whose platelets were most strongly reactive with the anti-Siba antibody (donor 3, Table 2 ) possessed homozygous GPIba alleles coding for Met145. The genotype of each individual whose platelets were unreactive with the antiSiba antibody was determined in every case to be homozygous Thr145-encoding alleles. Recombinant GPIba antigens demonstrate the epitope spec-$city of the anti-Sib" antibody. Two recombinant expression plasmids were constructed that direct the synthesis and secretion from heterologous cells of a soluble fragment of GPIba. The recombinant fragments essentially correspond to the extracytoplasmic 45-Kd domain of GPIba." One plasmid, designated ~M W 2 / T h r l~~, secretes GPIba residues 1 to 302 and contains a Thr145 codon. The other plasmid, designated ~M W 2 / M e t l~~, is identical to pMW2/ Thr145, with the exception that it contains a Met145 codon. CHO-K1 cells were transfected with either p I~l W 2 l T h r l~~ or ~M W 2 1 M e t l~~ and stable transformants were established. Both cell lines secreted GPIba antigen at similar levels, and functional assays revealed that both recombinant fragments, irrespective of Thr or Met at position 145, bound von Willebrand factor in the presence of ristocetin (data not shown, see Murata et all0). This result is consistent with the Thr/Met145 dimorphism being a naturally occurring polymorphism with no functional consequence for the normal interaction between von Willebrand factor and GPIb-IX.
Serum-free culture media from cells transfected with ~M W 2 1 T h r l~~ or ~M W 2 l M e t l~~ were serially diluted and reacted with the anti-GPIbaz71-z85 antipeptide polyclonal antibody to insure that similar antigen levels were present in the collected culture media.I0 Preliminary experiments demonstrated that the platelet epitope recognized by the anti-Siba antibody was sensitive to denaturation by sodium dodecyl sulfate (SDS). Therefore, to test immunoreactivity between the anti-Siba antibody and the recombinant fragments, serum-free culture media were analyzed after immobilization onto nitrocellulose in the absence of denaturants. anti-Siba antibody and culture medium from cells transfected with ~M W 2 / T h r l~~ or culture medium from untransfected CHO-K1 cells. Thus, the results of these experiments with recombinant antigens demonstrate that the substitution of the Thr145 amino acid with Met14s is sufficient to establish epitope specificity for the anti-Siba antibody.
Molecular bask for the generation of anti-Siba antibodies. Our results have established that the anti-Siba antibody specifically recognizes a recombinant GPIba alloantigen containing a methionine residue at position 145. It remains to be established whether this residue is directly part of the Siba epitope, or whether the amino acid substitution creates a conformational change responsible for the generation of a distant epitope recognized by the anti-Siba antibody. Indeed, conformation appears to be crucial in the reactivity of the anti-Siba antibody with its target antigen, as shown by the effect of denaturants (see above) and by the observation that the antibody reacts only with specific forms of platelet GPIba exhibiting a distinct electrophoretic mobility? Four polymorphic forms of platelet GPIba have been described,15J6 and three of these forms can be accounted for by genetic polymorphisms within the 0-linked carbohydraterich region of GPIba.17J8 Our recombinant molecules established that the generation of the Siba epitope is not dependent on polymorphisms within the carbohydrate-rich domain. Although it is possible that the Thr/Met dimorphism may be linked to another polymorphic form, the heterogeneous electrophoretic mobility of GPIb may also be due, at least in part, to conformational differences resulting from the dimorphic residue. Whether any genetic linkage exists among the different GPIba polymorphisms remains to be established.
On the basis of the present findings, it is possible to propose a model for the generation of the anti-Siba antibody in the original propositus.4 With respect to GPIba residue 145, this individual (who is not available for study) contained homozygous Thr145 codons. During transfusion therapy, the propositus received platelets whose GPIba contained Met'45, leading to the development of the antiSiba antibody (or a~~t i -M e t l~~) and platelet transfusion refractoriness after infusion of additional platelets containing Met'4s. Whether the converse happens, that is, antiThr145 antibodies develop in individuals who have homozygous Met145-encoding alleles, remains to be determined. However, in these individuals, such an event should be of common occurrence after transfusion therapy, in view of the higher frequency of the Thr'45 allele in the normal donor population (Table 1) . Another GPIb-IX-associated platelet alloantigen system, Koa/Kob, has been described in a preliminary report,19 but whether structural similarities exist between Koa/Kob and Siba remains to be determined.
In conclusion, while the identified dimorphism of GPIba does not explain every case of platelet transfusion refractoriness developing from HLA-matched platelet transfusions, the recognition of the molecular basis for the Siba antigen and anti-Siba antibody system provides an opportunity to match more closely donor and recipient platelet phenotypes. This should result in the avoidance of at least some cases of platelet transfusion refractoriness and benefit patients in need of multiple platelet transfusions to control bleeding episodes. 
